INFU InfuSystem Holdings, Inc

NYSE infusystem.com


$ 10.59 $ 1.07 (11.2 %)    

Wednesday, 05-Nov-2025 11:21:46 EST
QQQ $ 621.67 $ 3.22 (0.52 %)
DIA $ 470.56 $ -0.31 (-0.07 %)
SPY $ 677.02 $ 1.98 (0.29 %)
TLT $ 89.08 $ -0.43 (-0.48 %)
GLD $ 365.98 $ -0.47 (-0.13 %)
$ 9.46
$ 9.51
$ 10.56 x 1
$ 10.59 x 101
$ 9.51 - $ 10.64
$ 4.61 - $ 11.04
438,088
na
192.38M
$ 1.20
$ 34.63
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-11-2025 12-31-2024 10-K
5 11-08-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 04-09-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-16-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-15-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-22-2021 12-31-2020 10-K
21 11-13-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-15-2020 03-31-2020 10-Q
24 03-30-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 03-22-2019 12-31-2018 10-K
29 11-13-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-14-2018 03-31-2018 10-Q
32 03-19-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 03-22-2017 12-31-2016 10-K
37 12-12-2016 09-30-2016 10-Q
38 08-10-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 03-09-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 infusystems-holdings-affirms-fy2025-sales-guidance-of-142953m-145650m-vs-144147m-est

InfuSystems Holdings (AMEX:INFU) affirms FY2025 sales outlook from $142.953 million-$145.650 million to $142.953 million-$145.6...

 infusystems-holdings-q3-eps-011-beats-007-estimate-sales-36488m-miss-36806m-estimate

InfuSystems Holdings (AMEX:INFU) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0...

 lake-street-assumes-infusystems-holdings-at-buy-announces-price-target-of-15

Lake Street analyst Benjamin Haynor assumes InfuSystems Holdings (AMEX:INFU) with a Buy rating and announces Price Target of...

 infusystem-updates-its-annual-guidance-for-the-full-year-2025-with-net-revenue-growth-estimated-of-6-8-versus-prior-range-of-8-10

Full Year 2025 GuidanceInfuSystem is updating its annual guidance for the full year 2025 with net revenue growth estimated to b...

 roth-capital-initiates-coverage-on-infusystems-holdings-with-buy-rating-announces-price-target-of-12

Roth Capital analyst Kyle Bauser initiates coverage on InfuSystems Holdings (AMEX:INFU) with a Buy rating and announces Pric...

 infusystems-holdings-affirms-fy2025-sales-guidance-of-14565m-14835m-vs-14663m-est

InfuSystems Holdings (AMEX:INFU) affirms FY2025 sales outlook from $145.65 million-$148.35 million to $145.65 million-$148.35 m...

 infusystems-holdings-q1-eps-001-beats-004-estimate-sales-3472m-beat-3370m-estimate

InfuSystems Holdings (AMEX:INFU) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(...

 infusystem-estimates-2025-with-net-revenue-growth-of-8-to-10-with-adjusted-ebitda-margin-to-be-in-the-high-teens

InfuSystem is providing annual guidance for the full year 2025 with net revenue growth estimated to be in the 8% to 10% range. ...

 infusystems-holdings-q4-2024-gaap-eps-004-misses-007-estimate-sales-3385m-miss-3490m-estimate

InfuSystems Holdings (AMEX:INFU) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of ...

 infusystem-reiterates-its-2024-guidance-of-net-revenue-growth-expected-to-be-in-the-high-single-digit-range-and-adjusted-ebitda-to-be-in-the-high-teens

Full Year 2024 GuidanceInfuSystem is reaffirming its annual guidance for the full year 2024 with net revenue growth estimated t...

 infusystems-holdings-q3-2024-gaap-eps-008-beats-006-estimate-sales-35320m-beat-34483m-estimate

InfuSystems Holdings (AMEX:INFU) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0...

 b-riley-securities-initiates-coverage-on-infusystems-holdings-with-buy-rating-announces-price-target-of-13

B. Riley Securities initiates coverage on InfuSystems Holdings (AMEX:INFU) with a Buy rating and announces Price Target of $13.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION